De‐Yan Hou

1.0k total citations · 1 hit paper
15 papers, 876 citations indexed

About

De‐Yan Hou is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, De‐Yan Hou has authored 15 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in De‐Yan Hou's work include Radiopharmaceutical Chemistry and Applications (9 papers), RNA and protein synthesis mechanisms (5 papers) and Lung Cancer Treatments and Mutations (3 papers). De‐Yan Hou is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (9 papers), RNA and protein synthesis mechanisms (5 papers) and Lung Cancer Treatments and Mutations (3 papers). De‐Yan Hou collaborates with scholars based in United States and China. De‐Yan Hou's co-authors include David H. Munn, Madhav Sharma, Babak Baban, Scott Antonia, Pandelakis A. Koni, Jeffrey R. Lee, Jane L. Messina, Phillip Chandler, Andrew L. Mellor and Gerald S. Johnston and has published in prestigious journals such as Journal of Clinical Investigation, International Journal of Radiation Oncology*Biology*Physics and European Journal of Nuclear Medicine and Molecular Imaging.

In The Last Decade

De‐Yan Hou

15 papers receiving 861 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes

2004 700 citations David H. Munn, Madhav Sharma et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
De‐Yan Hou United States	8	468	305	249	183	122	15	876
P Sedlaczek Poland	13	59 0.1×	118 0.4×	133 0.5×	172 0.9×	63 0.5×	25	486
Ivan Cohen United States	8	259 0.6×	95 0.3×	212 0.9×	242 1.3×	20 0.2×	14	682
Laurence Gluch Australia	12	33 0.1×	100 0.3×	117 0.5×	165 0.9×	35 0.3×	19	596
Caroline Pabst Germany	17	296 0.6×	21 0.1×	156 0.6×	703 3.8×	31 0.3×	32	1.1k
Igor Cima Switzerland	14	146 0.3×	14 0.0×	209 0.8×	222 1.2×	48 0.4×	22	740
Robert Zerbib France	12	481 1.0×	12 0.0×	480 1.9×	115 0.6×	18 0.1×	26	722
Kevin O’Hayer United States	10	113 0.2×	38 0.1×	263 1.1×	315 1.7×	10 0.1×	18	568
Jason H. Williams United States	12	51 0.1×	33 0.1×	44 0.2×	319 1.7×	14 0.1×	27	532
Raluca A. Budiu United States	13	249 0.5×	7 0.0×	129 0.5×	230 1.3×	20 0.2×	14	646
Jessica M. Molkentine United States	14	26 0.1×	17 0.1×	270 1.1×	407 2.2×	12 0.1×	27	714

Countries citing papers authored by De‐Yan Hou

Since Specialization

Citations

This map shows the geographic impact of De‐Yan Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by De‐Yan Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites De‐Yan Hou more than expected).

Fields of papers citing papers by De‐Yan Hou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by De‐Yan Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by De‐Yan Hou. The network helps show where De‐Yan Hou may publish in the future.

Co-authorship network of co-authors of De‐Yan Hou

This figure shows the co-authorship network connecting the top 25 collaborators of De‐Yan Hou. A scholar is included among the top collaborators of De‐Yan Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with De‐Yan Hou. De‐Yan Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Munn, David H., Madhav Sharma, De‐Yan Hou, et al.. (2004). Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. Journal of Clinical Investigation. 114(2). 280–290. 700 indexed citations breakdown →

2.

Munn, David H., Madhav Sharma, De‐Yan Hou, et al.. (2004). Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. Journal of Clinical Investigation. 114(4). 599–599. 6 indexed citations

3.

Hou, De‐Yan & Yosh Maruyama. (1992). Distribution of ¹¹¹ in‐bleomycin complex in small cell lung cancer cells by autoradiography. Journal of Surgical Oncology. 49(2). 93–97. 14 indexed citations

4.

Hou, De‐Yan, et al.. (1992). Chromosome aberrations of human small cell lung cancer induced by a new ¹¹¹in‐bleomycin complex. Journal of Surgical Oncology. 51(4). 236–242. 4 indexed citations

5.

Howell, Roger W., Dandamudi V. Rao, De‐Yan Hou, Venkat Narra, & K.S.R. Sastry. (1991). The Question of Relative Biological Effectiveness and Quality Factor for Auger Emitters Incorporated into Proliferating Mammalian Cells. Radiation Research. 128(3). 282–282. 56 indexed citations

6.

Hou, De‐Yan, et al.. (1990). Enhanced killing of human small cell lung cancer by hyperthermia and lndium‐111‐ bleomycin complex. Journal of Surgical Oncology. 44(1). 5–9. 6 indexed citations

7.

Hou, De‐Yan, Anne W. Hamburger, J.L. Beach, & Yosh Maruyama. (1989). Killing of Human Lung Cancer Cells Using a New [¹¹¹In]Bleomycin Complex [¹¹¹In]BLMC. Cancer Investigation. 7(6). 543–550. 6 indexed citations

8.

Hou, De‐Yan, José V. Ordóñez, Richard Cross, Douglas D. Ross, & Yosh Maruyama. (1989). Killing lung cancer cells at cell‐cycle phase by a new indium‐111‐bleomycin complex. Journal of Surgical Oncology. 40(2). 73–78. 6 indexed citations

9.

Hou, De‐Yan, Hans Hoch, Gerald S. Johnston, et al.. (1985). A new ¹¹¹in‐bleomycin complex for combined radiotherapy and chemotherapy. Journal of Surgical Oncology. 29(2). 91–98. 14 indexed citations

10.

Hou, De‐Yan, et al.. (1985). Use of ¹¹¹in‐bleomycin for combining radiotherapy and chemotherapy on glioma‐bearing mice. Journal of Surgical Oncology. 29(2). 71–77. 5 indexed citations

11.

Hou, De‐Yan, et al.. (1984). Distribution and stability of [111In]bleomycin and its fractions in tumor-bearing mice. International Journal of Nuclear Medicine and Biology. 11(2). 129–139. 8 indexed citations

12.

Hou, De‐Yan, Hans Hoch, Gerald S. Johnston, et al.. (1984). A new tumor imaging agent‐¹¹¹In‐bleomycin complex. Comparison with ⁶⁷Ga‐citrate and ⁵⁷Co‐Bleomycin in tumor‐bearing animals. Journal of Surgical Oncology. 27(3). 189–195. 11 indexed citations

13.

Hou, De‐Yan, Hans Hoch, Gerald S. Johnston, et al.. (1984). A new ¹¹¹in‐bleomycin complex for tumor imaging: Preparation, stability, and distribution in glioma‐bearing mice. Journal of Surgical Oncology. 25(3). 168–175. 19 indexed citations

14.

Hou, De‐Yan, et al.. (1983). Stability of 111In-Bleomycin in vivo ?Properties compared with 57Co-bleomycin. European Journal of Nuclear Medicine and Molecular Imaging. 8(12). 535–40. 15 indexed citations

15.

Hou, De‐Yan, et al.. (1982). Stability of 111In-bleomycin in normal and tumor-bearing mice. International Journal of Radiation Oncology*Biology*Physics. 8(10). 1844–1845. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact